Home › Companies › TG THERAPEUTICS INC. › 2023-2024

TG THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and TG THERAPEUTICS INC.’s Form 8-K, filed June 17, 2024 (Item 5.07 on EDGAR). Page generated October 13, 2026.

10Ballot items
240Asset managers
1,970Fund votes
June 14, 2024Meeting date

Results at a glance

Meeting of June 14, 2024: 10 items on TG THERAPEUTICS INC.’s Form 8-K, filed June 17, 2024: 10 without a stated outcome.

Material dissent

Elect Director: Michael S. Weiss 75% of votes cast Outcome not stated Director under 80%
Elect Director: Laurence N. Charney 76% of votes cast Outcome not stated Director under 80%
Elect Director: Yann Echelard 46.1% of votes cast Outcome not stated Director under 80%
Elect Director: Kenneth Hoberman 68% of votes cast Outcome not stated Director under 80%
Elect Director: Daniel Hume 46.0% of votes cast Outcome not stated Director under 80%
Elect Director: Sagar Lonial, MD 44% of votes cast Outcome not stated Director under 80%
4. The vote to approve the amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of… 67% of votes cast Outcome not stated Under 80%
3. The advisory vote to approve the compensation of the Company's named executive officers 58% of votes cast Outcome not stated Say-on-pay under 70%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided · This season’s results screens

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TG THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by TG THERAPEUTICS INC.

These tallies are TG THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TG THERAPEUTICS INC. — official shareholder meeting results, meeting held June 14, 2024
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Michael S. Weiss	57,264,472	--	--	18,849,954	34,960,603	75%	Not verified	—
Elect Director: Laurence N. Charney	57,758,626	--	--	18,355,800	34,960,603	76%	Not verified	—
Elect Director: Yann Echelard	35,052,596	--	--	41,061,830	34,960,603	46.1%	Not verified	—
Elect Director: Kenneth Hoberman	52,058,723	--	--	24,055,703	34,960,603	68%	Not verified	—
Elect Director: Daniel Hume	35,036,823	--	--	41,077,603	34,960,603	46.0%	Not verified	—
Elect Director: Sagar Lonial, MD	33,299,870	--	--	42,814,556	34,960,603	44%	Not verified	—
2. The ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024	110,028,319	657,578	389,132	--	--	99.4%	Not verified	—
3. The advisory vote to approve the compensation of the Company's named executive officers	42,346,581	31,019,084	2,748,761	--	34,960,603	58%	Not verified	—
4. The vote to approve the amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock from 175,000,000 to 190,000,000	73,780,225	36,348,764	946,040	--	--	67%	Not verified	—
5. The vote to approve the amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit	66,744,142	8,625,685	744,599	--	34,960,603	89%	Not verified	—

Source: TG THERAPEUTICS INC., Form 8-K, filed with the SEC on June 17, 2024 — read the filing on EDGAR.

How asset managers voted at the TG THERAPEUTICS INC. 2023-2024 meeting

Each item below shows how the 240 asset managers that disclosed a TG THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Daniel Hume

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

46.0% Plurality election · of votes cast

FOR 46.0%WITHHELD

FOR: 35,036,823WITHHELD: 41,077,603

Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: Election of Directors: Daniel Hume

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Daniel Hume”): 35,036,823 for, 41,077,603 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 46.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 4,638,977 for, 20,108,064 withheld, 126,293 abstained.

FORWITHHOLD

FOR: 4,638,977ABSTAIN: 126,293WITHHOLD: 20,108,064

Largest asset managers voting on “Election of Directors: Daniel Hume” at TG THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Vanguard	3,066,304	0	13,143,664	Mixed
State Street	1,768	0	1,621,193	Withhold
TIAA	0	0	1,217,287	Withhold
Charles Schwab	0	0	1,148,610	Withhold
Fidelity	750,986	0	204,726	Mixed
BlackRock	0	0	877,944	Withhold
MUTUAL FUND SERIES TRUST	718,814	0	0	For
Equitable	0	0	374,322	Withhold
Lincoln Financial	0	0	177,050	Withhold
Direxion Shares ETF Trust	0	0	175,509	Withhold
First Trust	0	0	157,249	Withhold
Goldman Sachs	0	0	145,974	Withhold
QUANTITATIVE MASTER SERIES LLC	0	0	127,185	Withhold
SEI	0	0	110,717	Withhold
ProShares	0	0	101,760	Withhold
AIG/SunAmerica	0	0	71,446	Withhold
Global X	0	0	63,047	Withhold
Guggenheim	0	0	60,516	Withhold
John Hancock	0	50,793	0	Abstain
Pacific Life	0	0	47,089	Withhold
JPMorgan	0	46,996	0	Abstain
Voya	45,536	0	0	For
MASTER INVESTMENT PORTFOLIO	0	0	30,412	Withhold
New York Life	28,471	0	0	For
T. Rowe Price	0	0	27,853	Withhold

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

2. Elect Director: Kenneth Hoberman

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

68% Majority: yes · of votes cast

FOR 68%WITHHELD

FOR: 52,058,723WITHHELD: 24,055,703

Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: Election of Directors: Kenneth Hoberman

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kenneth Hoberman”): 52,058,723 for, 24,055,703 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 68% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 19,671,625 for, 5,075,416 withheld, 126,293 abstained.

FORWITHHOLD

FOR: 19,671,625ABSTAIN: 126,293WITHHOLD: 5,075,416

Largest asset managers voting on “Election of Directors: Kenneth Hoberman” at TG THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Vanguard	16,209,968	0	0	For
State Street	1,620,598	0	2,363	For
TIAA	0	0	1,217,287	Withhold
Charles Schwab	0	0	1,148,610	Withhold
Fidelity	879,790	0	75,922	Mixed
BlackRock	0	0	877,944	Withhold
MUTUAL FUND SERIES TRUST	718,814	0	0	For
Equitable	0	0	374,322	Withhold
Lincoln Financial	116,000	0	61,050	Mixed
Direxion Shares ETF Trust	0	0	175,509	Withhold
First Trust	0	0	157,249	Withhold
Goldman Sachs	0	0	145,974	Withhold
QUANTITATIVE MASTER SERIES LLC	0	0	127,185	Withhold
SEI	0	0	110,717	Withhold
ProShares	0	0	101,760	Withhold
AIG/SunAmerica	0	0	71,446	Withhold
Global X	0	0	63,047	Withhold
Guggenheim	0	0	60,516	Withhold
John Hancock	0	50,793	0	Abstain
Pacific Life	0	0	47,089	Withhold
JPMorgan	0	46,996	0	Abstain
Voya	45,536	0	0	For
MASTER INVESTMENT PORTFOLIO	0	0	30,412	Withhold
New York Life	28,471	0	0	For
T. Rowe Price	0	0	27,853	Withhold

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

3. Elect Director: Laurence N. Charney

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

76% Majority: yes · of votes cast

FOR 76%WITHHELD

FOR: 57,758,626WITHHELD: 18,355,800

Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: Election of Directors: Laurence Charney

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Laurence N. Charney”): 57,758,626 for, 18,355,800 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 21,075,399 for, 3,697,457 withheld, 100,478 abstained.

FORWITHHOLD

FOR: 21,075,399ABSTAIN: 100,478WITHHOLD: 3,697,457

Largest asset managers voting on “Election of Directors: Laurence Charney” at TG THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Vanguard	16,209,968	0	0	For
State Street	1,620,598	0	2,363	For
TIAA	0	0	1,217,287	Withhold
Charles Schwab	0	0	1,148,610	Withhold
Fidelity	953,572	0	2,140	For
BlackRock	877,944	0	0	For
MUTUAL FUND SERIES TRUST	718,814	0	0	For
Equitable	213,402	0	160,920	Mixed
Lincoln Financial	116,000	0	61,050	Mixed
Direxion Shares ETF Trust	0	0	175,509	Withhold
First Trust	0	0	157,249	Withhold
Goldman Sachs	0	0	145,974	Withhold
QUANTITATIVE MASTER SERIES LLC	127,185	0	0	For
SEI	0	0	110,717	Withhold
ProShares	0	0	101,760	Withhold
AIG/SunAmerica	0	0	71,446	Withhold
Global X	0	0	63,047	Withhold
Guggenheim	0	0	60,516	Withhold
John Hancock	0	50,793	0	Abstain
Pacific Life	47,089	0	0	For
JPMorgan	0	46,996	0	Abstain
Voya	45,536	0	0	For
MASTER INVESTMENT PORTFOLIO	30,412	0	0	For
New York Life	28,471	0	0	For
T. Rowe Price	0	0	27,853	Withhold

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

4. Elect Director: Michael S. Weiss

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

75% Majority: yes · of votes cast

FOR 75%WITHHELD

FOR: 57,264,472WITHHELD: 18,849,954

Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: Election of Directors: Michael S. Weiss

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael S. Weiss”): 57,264,472 for, 18,849,954 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 20,683,032 for, 4,139,496 withheld, 50,806 abstained.

FORWITHHOLD

FOR: 20,683,032ABSTAIN: 50,806WITHHOLD: 4,139,496

Largest asset managers voting on “Election of Directors: Michael S. Weiss” at TG THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Vanguard	16,209,968	0	0	For
State Street	1,768	0	1,621,193	Withhold
TIAA	0	0	1,217,287	Withhold
Charles Schwab	1,148,610	0	0	For
Fidelity	953,572	0	2,140	For
BlackRock	877,944	0	0	For
MUTUAL FUND SERIES TRUST	718,814	0	0	For
Equitable	213,402	0	160,920	Mixed
Lincoln Financial	0	0	177,050	Withhold
Direxion Shares ETF Trust	0	0	175,509	Withhold
First Trust	0	0	157,249	Withhold
Goldman Sachs	0	0	145,974	Withhold
QUANTITATIVE MASTER SERIES LLC	127,185	0	0	For
SEI	110,717	0	0	For
ProShares	0	0	101,760	Withhold
AIG/SunAmerica	0	0	71,446	Withhold
Global X	63,047	0	0	For
Guggenheim	0	0	60,516	Withhold
John Hancock	0	50,793	0	Abstain
Pacific Life	47,089	0	0	For
JPMorgan	46,996	0	0	For
Voya	0	0	45,536	Withhold
MASTER INVESTMENT PORTFOLIO	30,412	0	0	For
New York Life	28,471	0	0	For
T. Rowe Price	0	0	27,853	Withhold

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

5. Elect Director: Sagar Lonial, MD

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

44% Plurality election · of votes cast

FOR 44%WITHHELD

FOR: 33,299,870WITHHELD: 42,814,556

Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: Election of Directors: Sagar Lonial, MD

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Sagar Lonial, MD”): 33,299,870 for, 42,814,556 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 44% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 3,971,258 for, 20,775,783 withheld, 126,293 abstained.

FORWITHHOLD

FOR: 3,971,258ABSTAIN: 126,293WITHHOLD: 20,775,783

Largest asset managers voting on “Election of Directors: Sagar Lonial, MD” at TG THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Vanguard	3,066,304	0	13,143,664	Mixed
State Street	1,768	0	1,621,193	Withhold
TIAA	0	0	1,217,287	Withhold
Charles Schwab	0	0	1,148,610	Withhold
Fidelity	128,804	0	826,908	Mixed
BlackRock	0	0	877,944	Withhold
MUTUAL FUND SERIES TRUST	718,814	0	0	For
Equitable	0	0	374,322	Withhold
Lincoln Financial	0	0	177,050	Withhold
Direxion Shares ETF Trust	0	0	175,509	Withhold
First Trust	0	0	157,249	Withhold
Goldman Sachs	0	0	145,974	Withhold
QUANTITATIVE MASTER SERIES LLC	0	0	127,185	Withhold
SEI	0	0	110,717	Withhold
ProShares	0	0	101,760	Withhold
AIG/SunAmerica	0	0	71,446	Withhold
Global X	0	0	63,047	Withhold
Guggenheim	0	0	60,516	Withhold
John Hancock	0	50,793	0	Abstain
Pacific Life	0	0	47,089	Withhold
JPMorgan	0	46,996	0	Abstain
Voya	0	0	45,536	Withhold
MASTER INVESTMENT PORTFOLIO	0	0	30,412	Withhold
New York Life	28,471	0	0	For
T. Rowe Price	0	0	27,853	Withhold

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

6. Elect Director: Yann Echelard

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

46.1% Plurality election · of votes cast

FOR 46.1%WITHHELD

FOR: 35,052,596WITHHELD: 41,061,830

Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: Election of Directors: Yann Echelard

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Yann Echelard”): 35,052,596 for, 41,061,830 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 46.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 4,638,484 for, 20,108,557 withheld, 126,293 abstained.

FORWITHHOLD

FOR: 4,638,484ABSTAIN: 126,293WITHHOLD: 20,108,557

Largest asset managers voting on “Election of Directors: Yann Echelard” at TG THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Vanguard	3,066,304	0	13,143,664	Mixed
State Street	1,768	0	1,621,193	Withhold
TIAA	0	0	1,217,287	Withhold
Charles Schwab	0	0	1,148,610	Withhold
Fidelity	750,986	0	204,726	Mixed
BlackRock	0	0	877,944	Withhold
MUTUAL FUND SERIES TRUST	718,814	0	0	For
Equitable	0	0	374,322	Withhold
Lincoln Financial	0	0	177,050	Withhold
Direxion Shares ETF Trust	0	0	175,509	Withhold
First Trust	0	0	157,249	Withhold
Goldman Sachs	0	0	145,974	Withhold
QUANTITATIVE MASTER SERIES LLC	0	0	127,185	Withhold
SEI	0	0	110,717	Withhold
ProShares	0	0	101,760	Withhold
AIG/SunAmerica	0	0	71,446	Withhold
Global X	0	0	63,047	Withhold
Guggenheim	0	0	60,516	Withhold
John Hancock	0	50,793	0	Abstain
Pacific Life	0	0	47,089	Withhold
JPMorgan	0	46,996	0	Abstain
Voya	45,536	0	0	For
MASTER INVESTMENT PORTFOLIO	0	0	30,412	Withhold
New York Life	28,471	0	0	For
T. Rowe Price	0	0	27,853	Withhold

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

7. 4. The vote to approve the amendment to the Company's Amended and Restated Certificate of Incorporation to increase the…

Outcome not verifiedCAPITAL STRUCTUREReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

67% Majority: yes · of votes cast

FOR 67%AGAINST

FOR: 73,780,225AGAINST: 36,348,764

Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 175,000,000 TO 190,000,000.

TG THERAPEUTICS INC.’s own tally for this item (“4. The vote to approve the amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock from 175,000,000 to 190,000,000”): 73,780,225 for, 36,348,764 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 67% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 22,413,799 for, 2,463,299 against.

FOR

FOR: 22,413,799AGAINST: 2,463,299

Largest asset managers voting on “TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COM” at TG THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	16,209,968	0	For
State Street	1,620,598	2,363	For
TIAA	1,217,287	0	For
Charles Schwab	1,148,610	0	For
Fidelity	879,790	75,922	Mixed
BlackRock	0	877,944	Against
MUTUAL FUND SERIES TRUST	718,814	0	For
Equitable	0	374,322	Against
Lincoln Financial	116,000	61,050	Mixed
Direxion Shares ETF Trust	0	175,509	Against
First Trust	0	157,249	Against
Goldman Sachs	145,974	0	For
QUANTITATIVE MASTER SERIES LLC	0	127,185	Against
SEI	110,717	0	For
ProShares	0	101,760	Against
AIG/SunAmerica	0	71,446	Against
Global X	63,047	0	For
Guggenheim	0	60,516	Against
John Hancock	0	50,793	Against
Pacific Life	0	47,089	Against
JPMorgan	0	46,996	Against
Voya	0	45,536	Against
MASTER INVESTMENT PORTFOLIO	0	30,412	Against
New York Life	28,471	0	For
T. Rowe Price	27,853	0	For

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

8. 5. The vote to approve the amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit

Outcome not verified Fund totals may overlapCOMPENSATIONReported outcome: Not verified

Combines 7 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%

FOR: 66,744,142AGAINST: 8,625,685

Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: To approve amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit.

TG THERAPEUTICS INC.’s own tally for this item (“5. The vote to approve the amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit”): 66,744,142 for, 8,625,685 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 55 asset managers voting on “To approve amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit.” at TG THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	16,209,968	0	For
State Street	1,622,688	273	For
TIAA	1,217,287	0	For
Charles Schwab	1,148,610	0	For
Fidelity	955,712	0	For
BlackRock	877,944	0	For
MUTUAL FUND SERIES TRUST	718,814	0	For
Equitable	374,322	0	For
Lincoln Financial	177,050	0	For
Direxion Shares ETF Trust	175,509	0	For
First Trust	157,249	0	For
Goldman Sachs	145,974	0	For
QUANTITATIVE MASTER SERIES LLC	127,185	0	For
SEI	110,717	0	For
ProShares	101,760	0	For
AIG/SunAmerica	71,446	0	For
Global X	63,047	0	For
Guggenheim	60,516	0	For
John Hancock	50,793	0	For
Pacific Life	47,089	0	For
JPMorgan	46,996	0	For
Voya	45,536	0	For
MASTER INVESTMENT PORTFOLIO	30,412	0	For
New York Life	28,471	0	For
T. Rowe Price	27,853	0	For

Fund voting reports, all 55 managers: 24,836,815 for, 22,899 against, 13,620 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 4 asset managers voting on “To approve amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit.” at TG THERAPEUTICS INC., 2023-2024
Asset manager	For	Vote
Duquesne Family Office LLC	280,000	For
GRIMES & COMPANY, INC.	6,100	For
Jackson Creek Investment Advisors LLC	2,764	For
ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC	1,000	For

Institutional-manager reports, all 4 managers: 289,864 for.

9. 3. The advisory vote to approve the compensation of the Company's named executive officers

Outcome not verified Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 7 wordings of this item as funds reported it.

58% Majority: yes · of votes cast

FOR 58%AGAINST

FOR: 42,346,581AGAINST: 31,019,084

Details: description as filed, official tally, votes by 240 asset managers

Description as filed by funds: An advisory vote to approve the compensation of our named executive officers.

TG THERAPEUTICS INC.’s own tally for this item (“3. The advisory vote to approve the compensation of the Company's named executive officers”): 42,346,581 for, 31,019,084 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 58% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports: 56 asset managers voting on “An advisory vote to approve the compensation of our named executive officers.” at TG THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	13,143,664	3,066,304	Mixed
State Street	1,620,598	2,363	For
TIAA	0	1,217,287	Against
Charles Schwab	0	1,148,610	Against
Fidelity	128,804	826,908	Mixed
BlackRock	0	877,944	Against
MUTUAL FUND SERIES TRUST	0	718,814	Against
Equitable	0	374,322	Against
Lincoln Financial	116,000	61,050	Mixed
Direxion Shares ETF Trust	0	175,509	Against
First Trust	0	157,249	Against
Goldman Sachs	0	145,974	Against
QUANTITATIVE MASTER SERIES LLC	0	127,185	Against
SEI	0	110,717	Against
ProShares	0	101,760	Against
AIG/SunAmerica	0	71,446	Against
Global X	0	63,047	Against
Guggenheim	0	60,516	Against
John Hancock	0	50,793	Against
Pacific Life	0	47,089	Against
JPMorgan	0	46,996	Against
Voya	0	45,536	Against
MASTER INVESTMENT PORTFOLIO	0	30,412	Against
New York Life	0	28,471	Against
T. Rowe Price	0	27,853	Against

Fund voting reports, all 56 managers: 15,022,011 for, 9,849,970 against, 13,620 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 201 asset managers voting on “An advisory vote to approve the compensation of our named executive officers.” at TG THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
State Street	4,030,241	67,165	0	For
BlackRock	65,922	3,726,811	0	Against
Wellington	0	3,119,376	0	Against
PICTET ASSET MANAGEMENT SA	0	2,994,139	0	Against
Opaleye Management Inc.	0	0	1,830,000	Abstain
Nuveen	0	1,225,330	0	Against
Woodline Partners LP	1,151,525	0	0	For
Charles Schwab	0	1,148,610	0	Against
Vestal Point Capital, LP	0	935,993	0	Against
GEODE CAPITAL MANAGEMENT, LLC	0	885,427	0	Against
683 Capital Management, LLC	0	785,658	0	Against
Northern Trust	0	746,583	0	Against
Hood River Capital Management LLC	0	615,576	0	Against
Point72	0	407,194	0	Against
MELLON INVESTMENTS Corp	0	399,120	0	Against
Vanguard	395,612	0	0	For
JACOBS LEVY EQUITY MANAGEMENT, INC	0	376,682	0	Against
Soleus Capital Management, L.P.	360,879	0	0	For
Deep Track Capital, LP	301,832	0	0	For
Duquesne Family Office LLC	280,000	0	0	For
Sofinnova Investments, Inc.	0	253,478	0	Against
Citadel	247,989	0	0	For
NOMURA ASSET MANAGEMENT CO LTD	0	230,893	0	Against
Goldman Sachs	793	227,394	0	Against
Fidelity	170,174	46,512	0	Mixed

Institutional-manager reports, all 201 managers: 7,253,766 for, 20,918,945 against, 1,830,000 abstained, 29,688 not voted. Showing the 25 largest; see all in the interactive database.

10. 2. The ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 110,028,319AGAINST: 657,578

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2024.

TG THERAPEUTICS INC.’s own tally for this item (“2. The ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 110,028,319 for, 657,578 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 24,862,478 for, 13,620 abstained.

FOR

FOR: 24,862,478ABSTAIN: 13,620

Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING” at TG THERAPEUTICS INC., 2023-2024
Asset manager	For	Vote
Vanguard	16,209,968	For
State Street	1,622,961	For
TIAA	1,217,287	For
Charles Schwab	1,148,610	For
Fidelity	955,712	For
BlackRock	877,944	For
MUTUAL FUND SERIES TRUST	718,814	For
Equitable	374,322	For
Lincoln Financial	177,050	For
Direxion Shares ETF Trust	175,509	For
First Trust	157,249	For
Goldman Sachs	145,974	For
QUANTITATIVE MASTER SERIES LLC	127,185	For
SEI	110,717	For
ProShares	101,760	For
AIG/SunAmerica	71,446	For
Global X	63,047	For
Guggenheim	60,516	For
John Hancock	50,793	For
Pacific Life	47,089	For
JPMorgan	46,996	For
Voya	45,536	For
MASTER INVESTMENT PORTFOLIO	30,412	For
New York Life	28,471	For
T. Rowe Price	27,853	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

Largest TG THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 154,565,743 shares outstanding at the time of that meeting.

Fund voting reports: top TG THERAPEUTICS INC. shareholders by shares voted on “An advisory vote to approve the compensation of our named executive officers.”, 2023-2024
#	Asset manager	% of shares outstanding
1	Vanguard	10.49%
2	State Street	1.05%
3	TIAA	0.79%
4	Charles Schwab	0.74%
5	Fidelity	0.62%
6	BlackRock	0.57%
7	MUTUAL FUND SERIES TRUST	0.47%
8	Equitable	0.24%
9	Lincoln Financial	0.11%
10	Direxion Shares ETF Trust	0.11%

Institutional-manager reports: top TG THERAPEUTICS INC. shareholders by shares voted on “An advisory vote to approve the compensation of our named executive officers.”, 2023-2024
#	Asset manager	% of shares outstanding
1	State Street	2.65%
2	BlackRock	2.45%
3	Wellington	2.02%
4	PICTET ASSET MANAGEMENT SA	1.94%
5	Opaleye Management Inc.	1.18%
6	Nuveen	0.79%
7	Woodline Partners LP	0.75%
8	Charles Schwab	0.74%
9	Vestal Point Capital, LP	0.61%
10	GEODE CAPITAL MANAGEMENT, LLC	0.57%

Reported TG THERAPEUTICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

TG THERAPEUTICS INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
BlackRock	13.78%	13F
Vanguard Group	10.04%	13F
State Street	5.04%	13F
Millennium Management	2.29%	13F
Wellington Management	2.04%	13F
Geode Capital	2.01%	13F
Citadel Advisors	1.58%	13F
Nuveen	1.01%	13F
Goldman Sachs	0.98%	13F
Northern Trust	0.84%	13F

Percentages above are of 154,565,743 shares outstanding, as reported by TG THERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TG THERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 13, 2026; a live search always shows the current data.

At TG THERAPEUTICS INC.'s shareholder meeting held June 14, 2024, in the 2023-2024 proxy season, 240 asset managers reported how they voted on 10 ballot items in their SEC Form N-PX filings, covering 1,970 separate fund positions. On the most widely held item on that ballot — An advisory vote to approve the compensation of our named executive officers. — FOR was 58% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: TG THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2024.

TG THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.